Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Priest

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Chromatography|April 23, 1986
Micellar high-performance liquid chromatographic determination of folylpolyglutamate hydrolase activityL P Stratton, J B Hynes, D G Priest, et al.
Journal of Experimental Therapeutics & Oncology|November 6, 2002
Severe folate restriction results in depletion of and alteration in the composition of the intracellular folate pool, moderate sensitization to methotrexate and trimetrexate, upregulation of endogenous DHFR activity, and overexpression of metallothionein II and folate receptor alpha that, upon folate repletion, confer drug resistance to CHL cellsWei-Yong Zhu, M Bunni, D G Priest, et al.
Blood|July 15, 1994
Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemiaJ C Barredo, T W Synold, J Laver, et al.
Molecular Pharmacology|April 1, 1999
Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestrationG Jansen, H Barr, I Kathmann, et al.
International Journal of Cancer|November 3, 1995
Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivoS Miotti, P Facheris, A Tomassetti, et al.
Cancer Research|February 1, 1995
Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEMG Pizzorno, B A Moroson, A R Cashmore, et al.
The Journal of Biological Chemistry|November 7, 1998
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistanceG Jansen, R Mauritz, S Drori, et al.
Advances in Enzyme Regulation|January 1, 1997
Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cellsG Jansen, R M Mauritz, Y G Assaraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034H L McLeod, J Cassidy, R H Powrie, et al.
Cancer Research|April 28, 2001
Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitorsC L van der Wilt, H H Backus, K Smid, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Chromatography|April 23, 1986
Micellar high-performance liquid chromatographic determination of folylpolyglutamate hydrolase activityL P Stratton, J B Hynes, D G Priest, et al.
Journal of Experimental Therapeutics & Oncology|November 6, 2002
Severe folate restriction results in depletion of and alteration in the composition of the intracellular folate pool, moderate sensitization to methotrexate and trimetrexate, upregulation of endogenous DHFR activity, and overexpression of metallothionein II and folate receptor alpha that, upon folate repletion, confer drug resistance to CHL cellsWei-Yong Zhu, M Bunni, D G Priest, et al.
Blood|July 15, 1994
Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemiaJ C Barredo, T W Synold, J Laver, et al.
Molecular Pharmacology|April 1, 1999
Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestrationG Jansen, H Barr, I Kathmann, et al.
International Journal of Cancer|November 3, 1995
Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivoS Miotti, P Facheris, A Tomassetti, et al.
Cancer Research|February 1, 1995
Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEMG Pizzorno, B A Moroson, A R Cashmore, et al.
The Journal of Biological Chemistry|November 7, 1998
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistanceG Jansen, R Mauritz, S Drori, et al.
Advances in Enzyme Regulation|January 1, 1997
Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cellsG Jansen, R M Mauritz, Y G Assaraf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034H L McLeod, J Cassidy, R H Powrie, et al.
Cancer Research|April 28, 2001
Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitorsC L van der Wilt, H H Backus, K Smid, et al.
Pageof 5